Researchers recently discovered that the Rad51 promoter in cancer cells is on average 840-fold more active in cancer cells than in normal cells and the fusion of RAD51 promoter and diphtheria toxin gene selectively kills cancer cells. The gene discussed is RAD51; the disease is cancer.